5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology. (2017)

First Author: Beaufils F

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.7b00930

PubMed Identifier: 28829592

Publication URI: http://europepmc.org/abstract/MED/28829592

Type: Journal Article/Review

Volume: 60

Parent Publication: Journal of medicinal chemistry

Issue: 17

ISSN: 0022-2623